nodes	percent_of_prediction	percent_of_DWPC	metapath
Flucloxacillin—CYP3A4—Topotecan—lung cancer	0.0915	0.142	CbGbCtD
Flucloxacillin—CYP3A4—Gefitinib—lung cancer	0.0837	0.13	CbGbCtD
Flucloxacillin—CYP3A4—Teniposide—lung cancer	0.0811	0.126	CbGbCtD
Flucloxacillin—CYP3A4—Vinorelbine—lung cancer	0.0645	0.1	CbGbCtD
Flucloxacillin—CYP3A4—Crizotinib—lung cancer	0.0513	0.0796	CbGbCtD
Flucloxacillin—CYP3A4—Erlotinib—lung cancer	0.0495	0.0768	CbGbCtD
Flucloxacillin—CYP3A4—Paclitaxel—lung cancer	0.0453	0.0703	CbGbCtD
Flucloxacillin—CYP3A4—Irinotecan—lung cancer	0.0447	0.0694	CbGbCtD
Flucloxacillin—CYP3A4—Vinblastine—lung cancer	0.0397	0.0617	CbGbCtD
Flucloxacillin—CYP3A4—Etoposide—lung cancer	0.0358	0.0556	CbGbCtD
Flucloxacillin—CYP3A4—Docetaxel—lung cancer	0.0327	0.0508	CbGbCtD
Flucloxacillin—CYP3A4—Doxorubicin—lung cancer	0.0244	0.0379	CbGbCtD
Flucloxacillin—CYP3A4—Felbamate Metabolism—CYP2E1—lung cancer	0.00096	0.0907	CbGpPWpGaD
Flucloxacillin—CYP3A4—Codeine and Morphine Metabolism—ABCC3—lung cancer	0.000486	0.0459	CbGpPWpGaD
Flucloxacillin—CYP3A4—Codeine and Morphine Metabolism—UGT1A1—lung cancer	0.000457	0.0432	CbGpPWpGaD
Flucloxacillin—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—lung cancer	0.000428	0.0405	CbGpPWpGaD
Flucloxacillin—Myalgia—Cisplatin—lung cancer	0.000418	0.00121	CcSEcCtD
Flucloxacillin—Skin disorder—Gemcitabine—lung cancer	0.000417	0.00121	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Etoposide—lung cancer	0.000417	0.00121	CcSEcCtD
Flucloxacillin—Anaemia—Etoposide—lung cancer	0.000415	0.0012	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000415	0.0012	CcSEcCtD
Flucloxacillin—Dizziness—Topotecan—lung cancer	0.000413	0.0012	CcSEcCtD
Flucloxacillin—Discomfort—Cisplatin—lung cancer	0.000413	0.00119	CcSEcCtD
Flucloxacillin—Vomiting—Vinblastine—lung cancer	0.000409	0.00118	CcSEcCtD
Flucloxacillin—Dizziness—Erlotinib—lung cancer	0.000409	0.00118	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Paclitaxel—lung cancer	0.000409	0.00118	CcSEcCtD
Flucloxacillin—Anaemia—Paclitaxel—lung cancer	0.000407	0.00118	CcSEcCtD
Flucloxacillin—Erythema multiforme—Docetaxel—lung cancer	0.000406	0.00117	CcSEcCtD
Flucloxacillin—Malaise—Etoposide—lung cancer	0.000405	0.00117	CcSEcCtD
Flucloxacillin—Headache—Vinblastine—lung cancer	0.000403	0.00117	CcSEcCtD
Flucloxacillin—Angioedema—Paclitaxel—lung cancer	0.000403	0.00117	CcSEcCtD
Flucloxacillin—Toxic epidermal necrolysis—Methotrexate—lung cancer	0.000402	0.00117	CcSEcCtD
Flucloxacillin—Leukopenia—Etoposide—lung cancer	0.000402	0.00117	CcSEcCtD
Flucloxacillin—Purpura—Doxorubicin—lung cancer	0.000402	0.00116	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Cisplatin—lung cancer	0.0004	0.00116	CcSEcCtD
Flucloxacillin—Vomiting—Topotecan—lung cancer	0.000397	0.00115	CcSEcCtD
Flucloxacillin—Malaise—Paclitaxel—lung cancer	0.000397	0.00115	CcSEcCtD
Flucloxacillin—Leukopenia—Paclitaxel—lung cancer	0.000394	0.00114	CcSEcCtD
Flucloxacillin—Rash—Topotecan—lung cancer	0.000394	0.00114	CcSEcCtD
Flucloxacillin—Hypersensitivity—Vinorelbine—lung cancer	0.000394	0.00114	CcSEcCtD
Flucloxacillin—Dermatitis—Topotecan—lung cancer	0.000394	0.00114	CcSEcCtD
Flucloxacillin—Vomiting—Erlotinib—lung cancer	0.000393	0.00114	CcSEcCtD
Flucloxacillin—Nervous system disorder—Cisplatin—lung cancer	0.000393	0.00114	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Cisplatin—lung cancer	0.000392	0.00114	CcSEcCtD
Flucloxacillin—Headache—Topotecan—lung cancer	0.000391	0.00113	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000391	0.00113	CcSEcCtD
Flucloxacillin—Rash—Erlotinib—lung cancer	0.00039	0.00113	CcSEcCtD
Flucloxacillin—Dermatitis—Erlotinib—lung cancer	0.000389	0.00113	CcSEcCtD
Flucloxacillin—Convulsion—Etoposide—lung cancer	0.000389	0.00113	CcSEcCtD
Flucloxacillin—Skin disorder—Cisplatin—lung cancer	0.000389	0.00113	CcSEcCtD
Flucloxacillin—Dyspepsia—Irinotecan—lung cancer	0.000388	0.00112	CcSEcCtD
Flucloxacillin—Immune system disorder—Docetaxel—lung cancer	0.000387	0.00112	CcSEcCtD
Flucloxacillin—Headache—Erlotinib—lung cancer	0.000387	0.00112	CcSEcCtD
Flucloxacillin—Decreased appetite—Irinotecan—lung cancer	0.000383	0.00111	CcSEcCtD
Flucloxacillin—Eosinophilia—Methotrexate—lung cancer	0.000382	0.00111	CcSEcCtD
Flucloxacillin—Nausea—Vinblastine—lung cancer	0.000382	0.00111	CcSEcCtD
Flucloxacillin—Convulsion—Paclitaxel—lung cancer	0.000382	0.00111	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Irinotecan—lung cancer	0.000381	0.0011	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.00038	0.0011	CcSEcCtD
Flucloxacillin—Discomfort—Etoposide—lung cancer	0.000378	0.00109	CcSEcCtD
Flucloxacillin—Constipation—Irinotecan—lung cancer	0.000377	0.00109	CcSEcCtD
Flucloxacillin—Myalgia—Paclitaxel—lung cancer	0.000375	0.00109	CcSEcCtD
Flucloxacillin—Arthralgia—Paclitaxel—lung cancer	0.000375	0.00109	CcSEcCtD
Flucloxacillin—Decreased appetite—Gemcitabine—lung cancer	0.000373	0.00108	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000372	0.00108	CcSEcCtD
Flucloxacillin—Nausea—Topotecan—lung cancer	0.000371	0.00108	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000371	0.00107	CcSEcCtD
Flucloxacillin—Discomfort—Paclitaxel—lung cancer	0.000371	0.00107	CcSEcCtD
Flucloxacillin—Constipation—Gemcitabine—lung cancer	0.000367	0.00106	CcSEcCtD
Flucloxacillin—Nausea—Erlotinib—lung cancer	0.000367	0.00106	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Etoposide—lung cancer	0.000367	0.00106	CcSEcCtD
Flucloxacillin—Diarrhoea—Vinorelbine—lung cancer	0.000366	0.00106	CcSEcCtD
Flucloxacillin—Dysgeusia—Docetaxel—lung cancer	0.000366	0.00106	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000365	0.00106	CcSEcCtD
Flucloxacillin—Feeling abnormal—Irinotecan—lung cancer	0.000363	0.00105	CcSEcCtD
Flucloxacillin—Neutropenia—Methotrexate—lung cancer	0.000361	0.00105	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Irinotecan—lung cancer	0.000361	0.00104	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Paclitaxel—lung cancer	0.00036	0.00104	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Etoposide—lung cancer	0.000359	0.00104	CcSEcCtD
Flucloxacillin—Skin disorder—Etoposide—lung cancer	0.000356	0.00103	CcSEcCtD
Flucloxacillin—Feeling abnormal—Gemcitabine—lung cancer	0.000354	0.00103	CcSEcCtD
Flucloxacillin—Dizziness—Vinorelbine—lung cancer	0.000353	0.00102	CcSEcCtD
Flucloxacillin—Nervous system disorder—Paclitaxel—lung cancer	0.000353	0.00102	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Paclitaxel—lung cancer	0.000352	0.00102	CcSEcCtD
Flucloxacillin—Skin disorder—Paclitaxel—lung cancer	0.000349	0.00101	CcSEcCtD
Flucloxacillin—Body temperature increased—Irinotecan—lung cancer	0.000349	0.00101	CcSEcCtD
Flucloxacillin—Abdominal pain—Irinotecan—lung cancer	0.000349	0.00101	CcSEcCtD
Flucloxacillin—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.000348	0.00101	CcSEcCtD
Flucloxacillin—Decreased appetite—Cisplatin—lung cancer	0.000348	0.00101	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Cisplatin—lung cancer	0.000346	0.001	CcSEcCtD
Flucloxacillin—Anaemia—Docetaxel—lung cancer	0.000345	0.001	CcSEcCtD
Flucloxacillin—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000341	0.000989	CcSEcCtD
Flucloxacillin—Vomiting—Vinorelbine—lung cancer	0.00034	0.000984	CcSEcCtD
Flucloxacillin—Body temperature increased—Gemcitabine—lung cancer	0.000339	0.000983	CcSEcCtD
Flucloxacillin—Renal failure—Methotrexate—lung cancer	0.000339	0.000981	CcSEcCtD
Flucloxacillin—Rash—Vinorelbine—lung cancer	0.000337	0.000976	CcSEcCtD
Flucloxacillin—Dermatitis—Vinorelbine—lung cancer	0.000337	0.000975	CcSEcCtD
Flucloxacillin—Headache—Vinorelbine—lung cancer	0.000335	0.00097	CcSEcCtD
Flucloxacillin—Leukopenia—Docetaxel—lung cancer	0.000334	0.000968	CcSEcCtD
Flucloxacillin—Eosinophilia—Doxorubicin—lung cancer	0.000331	0.000959	CcSEcCtD
Flucloxacillin—Feeling abnormal—Cisplatin—lung cancer	0.00033	0.000955	CcSEcCtD
Flucloxacillin—Haematuria—Methotrexate—lung cancer	0.000328	0.000951	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000328	0.000949	CcSEcCtD
Flucloxacillin—Hepatobiliary disease—Methotrexate—lung cancer	0.000326	0.000943	CcSEcCtD
Flucloxacillin—Hypersensitivity—Irinotecan—lung cancer	0.000325	0.000941	CcSEcCtD
Flucloxacillin—Convulsion—Docetaxel—lung cancer	0.000324	0.000937	CcSEcCtD
Flucloxacillin—Agranulocytosis—Methotrexate—lung cancer	0.000321	0.000931	CcSEcCtD
Flucloxacillin—Decreased appetite—Etoposide—lung cancer	0.000319	0.000923	CcSEcCtD
Flucloxacillin—Myalgia—Docetaxel—lung cancer	0.000318	0.000921	CcSEcCtD
Flucloxacillin—Arthralgia—Docetaxel—lung cancer	0.000318	0.000921	CcSEcCtD
Flucloxacillin—Nausea—Vinorelbine—lung cancer	0.000318	0.00092	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Etoposide—lung cancer	0.000317	0.000917	CcSEcCtD
Flucloxacillin—Dyspepsia—Paclitaxel—lung cancer	0.000316	0.000917	CcSEcCtD
Flucloxacillin—Body temperature increased—Cisplatin—lung cancer	0.000316	0.000917	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000316	0.000915	CcSEcCtD
Flucloxacillin—Constipation—Etoposide—lung cancer	0.000314	0.000908	CcSEcCtD
Flucloxacillin—Neutropenia—Doxorubicin—lung cancer	0.000313	0.000906	CcSEcCtD
Flucloxacillin—Decreased appetite—Paclitaxel—lung cancer	0.000313	0.000905	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Paclitaxel—lung cancer	0.00031	0.000899	CcSEcCtD
Flucloxacillin—Hepatitis—Methotrexate—lung cancer	0.000309	0.000896	CcSEcCtD
Flucloxacillin—CYP3A4—Xenobiotics—CYP2A7—lung cancer	0.000308	0.0291	CbGpPWpGaD
Flucloxacillin—Constipation—Paclitaxel—lung cancer	0.000307	0.000891	CcSEcCtD
Flucloxacillin—Urinary tract disorder—Methotrexate—lung cancer	0.000305	0.000884	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Docetaxel—lung cancer	0.000305	0.000883	CcSEcCtD
Flucloxacillin—Urethral disorder—Methotrexate—lung cancer	0.000303	0.000878	CcSEcCtD
Flucloxacillin—Feeling abnormal—Etoposide—lung cancer	0.000302	0.000875	CcSEcCtD
Flucloxacillin—Diarrhoea—Irinotecan—lung cancer	0.000302	0.000874	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Etoposide—lung cancer	0.0003	0.000869	CcSEcCtD
Flucloxacillin—Nervous system disorder—Docetaxel—lung cancer	0.000299	0.000866	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Docetaxel—lung cancer	0.000298	0.000864	CcSEcCtD
Flucloxacillin—Feeling abnormal—Paclitaxel—lung cancer	0.000296	0.000858	CcSEcCtD
Flucloxacillin—Skin disorder—Docetaxel—lung cancer	0.000296	0.000857	CcSEcCtD
Flucloxacillin—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000296	0.000856	CcSEcCtD
Flucloxacillin—Hypersensitivity—Cisplatin—lung cancer	0.000295	0.000854	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Paclitaxel—lung cancer	0.000294	0.000852	CcSEcCtD
Flucloxacillin—Diarrhoea—Gemcitabine—lung cancer	0.000294	0.000851	CcSEcCtD
Flucloxacillin—Renal failure—Doxorubicin—lung cancer	0.000293	0.000849	CcSEcCtD
Flucloxacillin—Erythema multiforme—Methotrexate—lung cancer	0.000292	0.000847	CcSEcCtD
Flucloxacillin—CYP3A4—Irinotecan Pathway—UGT1A1—lung cancer	0.000292	0.0276	CbGpPWpGaD
Flucloxacillin—Dizziness—Irinotecan—lung cancer	0.000292	0.000844	CcSEcCtD
Flucloxacillin—Urticaria—Etoposide—lung cancer	0.000291	0.000844	CcSEcCtD
Flucloxacillin—Jaundice—Doxorubicin—lung cancer	0.000291	0.000842	CcSEcCtD
Flucloxacillin—Abdominal pain—Etoposide—lung cancer	0.00029	0.00084	CcSEcCtD
Flucloxacillin—Body temperature increased—Etoposide—lung cancer	0.00029	0.00084	CcSEcCtD
Flucloxacillin—Urticaria—Paclitaxel—lung cancer	0.000286	0.000827	CcSEcCtD
Flucloxacillin—Haematuria—Doxorubicin—lung cancer	0.000284	0.000824	CcSEcCtD
Flucloxacillin—Body temperature increased—Paclitaxel—lung cancer	0.000284	0.000823	CcSEcCtD
Flucloxacillin—Abdominal pain—Paclitaxel—lung cancer	0.000284	0.000823	CcSEcCtD
Flucloxacillin—Hepatobiliary disease—Doxorubicin—lung cancer	0.000282	0.000817	CcSEcCtD
Flucloxacillin—Vomiting—Irinotecan—lung cancer	0.00028	0.000812	CcSEcCtD
Flucloxacillin—Immune system disorder—Methotrexate—lung cancer	0.000279	0.000809	CcSEcCtD
Flucloxacillin—Agranulocytosis—Doxorubicin—lung cancer	0.000278	0.000806	CcSEcCtD
Flucloxacillin—Rash—Irinotecan—lung cancer	0.000278	0.000805	CcSEcCtD
Flucloxacillin—Dermatitis—Irinotecan—lung cancer	0.000278	0.000804	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000278	0.000804	CcSEcCtD
Flucloxacillin—Headache—Irinotecan—lung cancer	0.000276	0.0008	CcSEcCtD
Flucloxacillin—Diarrhoea—Cisplatin—lung cancer	0.000274	0.000793	CcSEcCtD
Flucloxacillin—Vomiting—Gemcitabine—lung cancer	0.000273	0.000791	CcSEcCtD
Flucloxacillin—Rash—Gemcitabine—lung cancer	0.000271	0.000784	CcSEcCtD
Flucloxacillin—Dermatitis—Gemcitabine—lung cancer	0.000271	0.000784	CcSEcCtD
Flucloxacillin—Hypersensitivity—Etoposide—lung cancer	0.00027	0.000783	CcSEcCtD
Flucloxacillin—Headache—Gemcitabine—lung cancer	0.000269	0.000779	CcSEcCtD
Flucloxacillin—Dyspepsia—Docetaxel—lung cancer	0.000268	0.000777	CcSEcCtD
Flucloxacillin—Hepatitis—Doxorubicin—lung cancer	0.000268	0.000775	CcSEcCtD
Flucloxacillin—CYP3A4—Aflatoxin B1 metabolism—GSTM1—lung cancer	0.000267	0.0252	CbGpPWpGaD
Flucloxacillin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC3—lung cancer	0.000266	0.0251	CbGpPWpGaD
Flucloxacillin—Decreased appetite—Docetaxel—lung cancer	0.000265	0.000767	CcSEcCtD
Flucloxacillin—Hypersensitivity—Paclitaxel—lung cancer	0.000265	0.000767	CcSEcCtD
Flucloxacillin—Urinary tract disorder—Doxorubicin—lung cancer	0.000264	0.000766	CcSEcCtD
Flucloxacillin—Dysgeusia—Methotrexate—lung cancer	0.000264	0.000763	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Docetaxel—lung cancer	0.000263	0.000762	CcSEcCtD
Flucloxacillin—Connective tissue disorder—Doxorubicin—lung cancer	0.000263	0.000762	CcSEcCtD
Flucloxacillin—Urethral disorder—Doxorubicin—lung cancer	0.000262	0.00076	CcSEcCtD
Flucloxacillin—Nausea—Irinotecan—lung cancer	0.000262	0.000759	CcSEcCtD
Flucloxacillin—Constipation—Docetaxel—lung cancer	0.000261	0.000755	CcSEcCtD
Flucloxacillin—CYP3A4—Estrogen metabolism—GSTA1—lung cancer	0.000257	0.0243	CbGpPWpGaD
Flucloxacillin—Nausea—Gemcitabine—lung cancer	0.000255	0.000739	CcSEcCtD
Flucloxacillin—Vomiting—Cisplatin—lung cancer	0.000255	0.000737	CcSEcCtD
Flucloxacillin—CYP3A4—Irinotecan Pathway—ABCG2—lung cancer	0.000253	0.0239	CbGpPWpGaD
Flucloxacillin—Erythema multiforme—Doxorubicin—lung cancer	0.000253	0.000733	CcSEcCtD
Flucloxacillin—Rash—Cisplatin—lung cancer	0.000252	0.000731	CcSEcCtD
Flucloxacillin—Dermatitis—Cisplatin—lung cancer	0.000252	0.00073	CcSEcCtD
Flucloxacillin—Feeling abnormal—Docetaxel—lung cancer	0.000251	0.000727	CcSEcCtD
Flucloxacillin—Diarrhoea—Etoposide—lung cancer	0.000251	0.000727	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Methotrexate—lung cancer	0.00025	0.000723	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Docetaxel—lung cancer	0.000249	0.000722	CcSEcCtD
Flucloxacillin—Anaemia—Methotrexate—lung cancer	0.000249	0.000721	CcSEcCtD
Flucloxacillin—CYP3A4—Codeine and Morphine Metabolism—ABCB1—lung cancer	0.000247	0.0234	CbGpPWpGaD
Flucloxacillin—Diarrhoea—Paclitaxel—lung cancer	0.000246	0.000713	CcSEcCtD
Flucloxacillin—Malaise—Methotrexate—lung cancer	0.000243	0.000703	CcSEcCtD
Flucloxacillin—Dizziness—Etoposide—lung cancer	0.000242	0.000702	CcSEcCtD
Flucloxacillin—Immune system disorder—Doxorubicin—lung cancer	0.000242	0.0007	CcSEcCtD
Flucloxacillin—Abdominal pain—Docetaxel—lung cancer	0.000241	0.000698	CcSEcCtD
Flucloxacillin—Body temperature increased—Docetaxel—lung cancer	0.000241	0.000698	CcSEcCtD
Flucloxacillin—Leukopenia—Methotrexate—lung cancer	0.000241	0.000698	CcSEcCtD
Flucloxacillin—CYP3A4—Estrogen metabolism—UGT1A1—lung cancer	0.000239	0.0226	CbGpPWpGaD
Flucloxacillin—Dizziness—Paclitaxel—lung cancer	0.000238	0.000689	CcSEcCtD
Flucloxacillin—Nausea—Cisplatin—lung cancer	0.000238	0.000689	CcSEcCtD
Flucloxacillin—Convulsion—Methotrexate—lung cancer	0.000233	0.000675	CcSEcCtD
Flucloxacillin—Vomiting—Etoposide—lung cancer	0.000233	0.000675	CcSEcCtD
Flucloxacillin—Rash—Etoposide—lung cancer	0.000231	0.00067	CcSEcCtD
Flucloxacillin—Dermatitis—Etoposide—lung cancer	0.000231	0.000669	CcSEcCtD
Flucloxacillin—Headache—Etoposide—lung cancer	0.00023	0.000665	CcSEcCtD
Flucloxacillin—Myalgia—Methotrexate—lung cancer	0.000229	0.000664	CcSEcCtD
Flucloxacillin—Arthralgia—Methotrexate—lung cancer	0.000229	0.000664	CcSEcCtD
Flucloxacillin—Vomiting—Paclitaxel—lung cancer	0.000229	0.000662	CcSEcCtD
Flucloxacillin—Dysgeusia—Doxorubicin—lung cancer	0.000228	0.000661	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000228	0.000659	CcSEcCtD
Flucloxacillin—Rash—Paclitaxel—lung cancer	0.000227	0.000657	CcSEcCtD
Flucloxacillin—Dermatitis—Paclitaxel—lung cancer	0.000226	0.000656	CcSEcCtD
Flucloxacillin—Discomfort—Methotrexate—lung cancer	0.000226	0.000656	CcSEcCtD
Flucloxacillin—Headache—Paclitaxel—lung cancer	0.000225	0.000652	CcSEcCtD
Flucloxacillin—Hypersensitivity—Docetaxel—lung cancer	0.000225	0.00065	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Methotrexate—lung cancer	0.00022	0.000636	CcSEcCtD
Flucloxacillin—Nausea—Etoposide—lung cancer	0.000218	0.000631	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Doxorubicin—lung cancer	0.000216	0.000626	CcSEcCtD
Flucloxacillin—Nervous system disorder—Methotrexate—lung cancer	0.000215	0.000624	CcSEcCtD
Flucloxacillin—Anaemia—Doxorubicin—lung cancer	0.000215	0.000624	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Methotrexate—lung cancer	0.000215	0.000623	CcSEcCtD
Flucloxacillin—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—lung cancer	0.000214	0.0202	CbGpPWpGaD
Flucloxacillin—Nausea—Paclitaxel—lung cancer	0.000214	0.000619	CcSEcCtD
Flucloxacillin—Skin disorder—Methotrexate—lung cancer	0.000213	0.000618	CcSEcCtD
Flucloxacillin—Malaise—Doxorubicin—lung cancer	0.00021	0.000609	CcSEcCtD
Flucloxacillin—Leukopenia—Doxorubicin—lung cancer	0.000209	0.000604	CcSEcCtD
Flucloxacillin—Diarrhoea—Docetaxel—lung cancer	0.000209	0.000604	CcSEcCtD
Flucloxacillin—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—lung cancer	0.000207	0.0196	CbGpPWpGaD
Flucloxacillin—Convulsion—Doxorubicin—lung cancer	0.000202	0.000585	CcSEcCtD
Flucloxacillin—Dizziness—Docetaxel—lung cancer	0.000202	0.000584	CcSEcCtD
Flucloxacillin—CYP3A4—Tryptophan metabolism—HSD17B10—lung cancer	0.0002	0.0189	CbGpPWpGaD
Flucloxacillin—Musculoskeletal discomfort—Methotrexate—lung cancer	0.0002	0.00058	CcSEcCtD
Flucloxacillin—Arthralgia—Doxorubicin—lung cancer	0.000198	0.000575	CcSEcCtD
Flucloxacillin—Myalgia—Doxorubicin—lung cancer	0.000198	0.000575	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000197	0.000571	CcSEcCtD
Flucloxacillin—Discomfort—Doxorubicin—lung cancer	0.000196	0.000568	CcSEcCtD
Flucloxacillin—Vomiting—Docetaxel—lung cancer	0.000194	0.000561	CcSEcCtD
Flucloxacillin—Dyspepsia—Methotrexate—lung cancer	0.000193	0.00056	CcSEcCtD
Flucloxacillin—Rash—Docetaxel—lung cancer	0.000192	0.000557	CcSEcCtD
Flucloxacillin—Dermatitis—Docetaxel—lung cancer	0.000192	0.000556	CcSEcCtD
Flucloxacillin—Decreased appetite—Methotrexate—lung cancer	0.000191	0.000553	CcSEcCtD
Flucloxacillin—Headache—Docetaxel—lung cancer	0.000191	0.000553	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Doxorubicin—lung cancer	0.00019	0.000551	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Methotrexate—lung cancer	0.00019	0.000549	CcSEcCtD
Flucloxacillin—Nervous system disorder—Doxorubicin—lung cancer	0.000187	0.00054	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Doxorubicin—lung cancer	0.000186	0.000539	CcSEcCtD
Flucloxacillin—Skin disorder—Doxorubicin—lung cancer	0.000185	0.000535	CcSEcCtD
Flucloxacillin—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—lung cancer	0.000182	0.0172	CbGpPWpGaD
Flucloxacillin—Nausea—Docetaxel—lung cancer	0.000181	0.000524	CcSEcCtD
Flucloxacillin—Feeling abnormal—Methotrexate—lung cancer	0.000181	0.000524	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Methotrexate—lung cancer	0.00018	0.00052	CcSEcCtD
Flucloxacillin—CYP3A4—Xenobiotics—CYP2A6—lung cancer	0.000179	0.0169	CbGpPWpGaD
Flucloxacillin—Urticaria—Methotrexate—lung cancer	0.000174	0.000505	CcSEcCtD
Flucloxacillin—Abdominal pain—Methotrexate—lung cancer	0.000174	0.000503	CcSEcCtD
Flucloxacillin—Body temperature increased—Methotrexate—lung cancer	0.000174	0.000503	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000173	0.000502	CcSEcCtD
Flucloxacillin—CYP3A4—Tamoxifen metabolism—CYP2A6—lung cancer	0.000172	0.0163	CbGpPWpGaD
Flucloxacillin—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—lung cancer	0.000168	0.0159	CbGpPWpGaD
Flucloxacillin—Dyspepsia—Doxorubicin—lung cancer	0.000167	0.000485	CcSEcCtD
Flucloxacillin—Decreased appetite—Doxorubicin—lung cancer	0.000165	0.000479	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000164	0.000476	CcSEcCtD
Flucloxacillin—CYP3A4—Estrogen metabolism—NQO1—lung cancer	0.000164	0.0155	CbGpPWpGaD
Flucloxacillin—Constipation—Doxorubicin—lung cancer	0.000163	0.000471	CcSEcCtD
Flucloxacillin—Hypersensitivity—Methotrexate—lung cancer	0.000162	0.000469	CcSEcCtD
Flucloxacillin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC3—lung cancer	0.00016	0.0152	CbGpPWpGaD
Flucloxacillin—Feeling abnormal—Doxorubicin—lung cancer	0.000157	0.000454	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Doxorubicin—lung cancer	0.000156	0.000451	CcSEcCtD
Flucloxacillin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—lung cancer	0.000153	0.0144	CbGpPWpGaD
Flucloxacillin—CYP3A4—Xenobiotics—CYP2E1—lung cancer	0.000152	0.0144	CbGpPWpGaD
Flucloxacillin—Urticaria—Doxorubicin—lung cancer	0.000151	0.000438	CcSEcCtD
Flucloxacillin—CYP3A4—Constitutive Androstane Receptor Pathway—UGT1A1—lung cancer	0.000151	0.0142	CbGpPWpGaD
Flucloxacillin—Abdominal pain—Doxorubicin—lung cancer	0.00015	0.000436	CcSEcCtD
Flucloxacillin—Body temperature increased—Doxorubicin—lung cancer	0.00015	0.000436	CcSEcCtD
Flucloxacillin—Diarrhoea—Methotrexate—lung cancer	0.00015	0.000435	CcSEcCtD
Flucloxacillin—CYP3A4—Tamoxifen metabolism—CYP2E1—lung cancer	0.000146	0.0138	CbGpPWpGaD
Flucloxacillin—Dizziness—Methotrexate—lung cancer	0.000145	0.000421	CcSEcCtD
Flucloxacillin—Hypersensitivity—Doxorubicin—lung cancer	0.00014	0.000406	CcSEcCtD
Flucloxacillin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—lung cancer	0.00014	0.0132	CbGpPWpGaD
Flucloxacillin—Vomiting—Methotrexate—lung cancer	0.00014	0.000405	CcSEcCtD
Flucloxacillin—Rash—Methotrexate—lung cancer	0.000138	0.000401	CcSEcCtD
Flucloxacillin—Dermatitis—Methotrexate—lung cancer	0.000138	0.000401	CcSEcCtD
Flucloxacillin—Headache—Methotrexate—lung cancer	0.000138	0.000399	CcSEcCtD
Flucloxacillin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—lung cancer	0.000135	0.0128	CbGpPWpGaD
Flucloxacillin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—lung cancer	0.000131	0.0124	CbGpPWpGaD
Flucloxacillin—Nausea—Methotrexate—lung cancer	0.00013	0.000378	CcSEcCtD
Flucloxacillin—Diarrhoea—Doxorubicin—lung cancer	0.00013	0.000377	CcSEcCtD
Flucloxacillin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—lung cancer	0.000128	0.0121	CbGpPWpGaD
Flucloxacillin—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—lung cancer	0.000126	0.0119	CbGpPWpGaD
Flucloxacillin—Dizziness—Doxorubicin—lung cancer	0.000126	0.000364	CcSEcCtD
Flucloxacillin—CYP3A4—Estrogen metabolism—GSTM1—lung cancer	0.000125	0.0119	CbGpPWpGaD
Flucloxacillin—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—lung cancer	0.000123	0.0116	CbGpPWpGaD
Flucloxacillin—Vomiting—Doxorubicin—lung cancer	0.000121	0.00035	CcSEcCtD
Flucloxacillin—Rash—Doxorubicin—lung cancer	0.00012	0.000347	CcSEcCtD
Flucloxacillin—Dermatitis—Doxorubicin—lung cancer	0.00012	0.000347	CcSEcCtD
Flucloxacillin—Headache—Doxorubicin—lung cancer	0.000119	0.000345	CcSEcCtD
Flucloxacillin—CYP3A4—Estrogen metabolism—CYP1A1—lung cancer	0.000119	0.0112	CbGpPWpGaD
Flucloxacillin—CYP3A4—Irinotecan Pathway—APC—lung cancer	0.000114	0.0108	CbGpPWpGaD
Flucloxacillin—Nausea—Doxorubicin—lung cancer	0.000113	0.000327	CcSEcCtD
Flucloxacillin—CYP3A4—Xenobiotics—CYP1A1—lung cancer	0.000109	0.0103	CbGpPWpGaD
Flucloxacillin—CYP3A4—Tamoxifen metabolism—CYP1A1—lung cancer	0.000105	0.00994	CbGpPWpGaD
Flucloxacillin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—lung cancer	0.000104	0.0098	CbGpPWpGaD
Flucloxacillin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—lung cancer	9.95e-05	0.00941	CbGpPWpGaD
Flucloxacillin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—lung cancer	8.16e-05	0.00771	CbGpPWpGaD
Flucloxacillin—CYP3A4—Tryptophan metabolism—CYP2E1—lung cancer	7.82e-05	0.00739	CbGpPWpGaD
Flucloxacillin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—lung cancer	7.77e-05	0.00734	CbGpPWpGaD
Flucloxacillin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—lung cancer	7.43e-05	0.00702	CbGpPWpGaD
Flucloxacillin—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—lung cancer	7.33e-05	0.00693	CbGpPWpGaD
Flucloxacillin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	6.32e-05	0.00597	CbGpPWpGaD
Flucloxacillin—CYP3A4—Tryptophan metabolism—CAT—lung cancer	6.27e-05	0.00593	CbGpPWpGaD
Flucloxacillin—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—lung cancer	6.24e-05	0.00589	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—GSTM2—lung cancer	6.09e-05	0.00576	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—CNDP2—lung cancer	6.09e-05	0.00576	CbGpPWpGaD
Flucloxacillin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	6.03e-05	0.00569	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metapathway biotransformation—GSTM2—lung cancer	6.01e-05	0.00568	CbGpPWpGaD
Flucloxacillin—CYP3A4—Tryptophan metabolism—CYP1A1—lung cancer	5.62e-05	0.00531	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—CYP2A7—lung cancer	5.51e-05	0.00521	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metapathway biotransformation—CYP2A7—lung cancer	5.43e-05	0.00514	CbGpPWpGaD
Flucloxacillin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	5.12e-05	0.00484	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—GSTA3—lung cancer	4.91e-05	0.00464	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metapathway biotransformation—GSTA3—lung cancer	4.84e-05	0.00458	CbGpPWpGaD
Flucloxacillin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	4.54e-05	0.00429	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—GSTA4—lung cancer	4.49e-05	0.00424	CbGpPWpGaD
Flucloxacillin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—lung cancer	4.48e-05	0.00423	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metapathway biotransformation—GSTA4—lung cancer	4.43e-05	0.00419	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—GSTA2—lung cancer	4.38e-05	0.00414	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—GSTA1—lung cancer	4.22e-05	0.00399	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metapathway biotransformation—AKR1C1—lung cancer	3.99e-05	0.00377	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—UGT1A1—lung cancer	3.93e-05	0.00371	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	3.87e-05	0.00366	CbGpPWpGaD
Flucloxacillin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	3.68e-05	0.00348	CbGpPWpGaD
Flucloxacillin—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	3.46e-05	0.00327	CbGpPWpGaD
Flucloxacillin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	3.39e-05	0.0032	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—HPGDS—lung cancer	3.34e-05	0.00315	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—GSTT1—lung cancer	3.24e-05	0.00306	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—GCLC—lung cancer	3.2e-05	0.00302	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—CYP2A6—lung cancer	3.2e-05	0.00302	CbGpPWpGaD
Flucloxacillin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	2.74e-05	0.00259	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—CYP2E1—lung cancer	2.72e-05	0.00257	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	2.68e-05	0.00254	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—GSTP1—lung cancer	2.24e-05	0.00212	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	2.21e-05	0.00209	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—GSTM1—lung cancer	2.06e-05	0.00195	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	2.03e-05	0.00192	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—CYP1A1—lung cancer	1.96e-05	0.00185	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	1.93e-05	0.00182	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—COL4A3BP—lung cancer	1.72e-05	0.00163	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—AZIN2—lung cancer	1.72e-05	0.00163	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—ATP5H—lung cancer	1.46e-05	0.00138	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—POMC—lung cancer	1.46e-05	0.00138	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—PLBD1—lung cancer	1.3e-05	0.00123	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—HSD17B10—lung cancer	1.19e-05	0.00113	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—CKB—lung cancer	1.11e-05	0.00105	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—CNDP2—lung cancer	1.04e-05	0.000985	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—GSTM2—lung cancer	1.04e-05	0.000985	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—MTMR3—lung cancer	1.01e-05	0.000958	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—PGAM1—lung cancer	9.88e-06	0.000933	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—CYP2A7—lung cancer	9.42e-06	0.00089	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—SDC4—lung cancer	9.22e-06	0.000871	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—GSTA3—lung cancer	8.4e-06	0.000794	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—RRM1—lung cancer	8.4e-06	0.000794	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—B4GALT5—lung cancer	7.9e-06	0.000746	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—GSTA4—lung cancer	7.68e-06	0.000726	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—GSTA2—lung cancer	7.49e-06	0.000707	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—GSTA1—lung cancer	7.22e-06	0.000682	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—ABCC3—lung cancer	7.14e-06	0.000675	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—AKR1C1—lung cancer	6.92e-06	0.000654	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—UGT1A1—lung cancer	6.71e-06	0.000634	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—GNG11—lung cancer	6.47e-06	0.000612	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—ALDOA—lung cancer	6.16e-06	0.000582	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—NCOA3—lung cancer	5.98e-06	0.000565	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—ABCG2—lung cancer	5.82e-06	0.00055	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—ADCY1—lung cancer	5.82e-06	0.00055	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—ENO2—lung cancer	5.71e-06	0.000539	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—HPGDS—lung cancer	5.71e-06	0.000539	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—PPP2R1B—lung cancer	5.67e-06	0.000536	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—GSTT1—lung cancer	5.54e-06	0.000523	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—CYP2A6—lung cancer	5.47e-06	0.000517	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—GCLC—lung cancer	5.47e-06	0.000517	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—ENO1—lung cancer	5.19e-06	0.00049	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—CYP2E1—lung cancer	4.65e-06	0.00044	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—NQO1—lung cancer	4.6e-06	0.000435	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—STK11—lung cancer	4.15e-06	0.000392	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—GSTP1—lung cancer	3.84e-06	0.000363	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—CAT—lung cancer	3.73e-06	0.000353	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—ABCB1—lung cancer	3.63e-06	0.000343	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—TYMS—lung cancer	3.57e-06	0.000337	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—GSTM1—lung cancer	3.53e-06	0.000333	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—CYP1A1—lung cancer	3.34e-06	0.000316	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—ERCC2—lung cancer	3.32e-06	0.000313	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—APOA1—lung cancer	2.87e-06	0.000271	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—PIK3CG—lung cancer	2.62e-06	0.000247	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—POMC—lung cancer	2.49e-06	0.000236	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—CREBBP—lung cancer	2.43e-06	0.000229	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—PIK3CD—lung cancer	2.3e-06	0.000218	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—ALB—lung cancer	2.27e-06	0.000215	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—PIK3CB—lung cancer	2.01e-06	0.00019	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—PTGS2—lung cancer	1.99e-06	0.000188	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—PTEN—lung cancer	1.73e-06	0.000164	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—EP300—lung cancer	1.65e-06	0.000156	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—PIK3CA—lung cancer	1.22e-06	0.000116	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—AKT1—lung cancer	9.99e-07	9.44e-05	CbGpPWpGaD
